Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination Coronavirus Disease COVID SARSCoV2 tachycardia NatureCVR karolinskainst UBuffalo
By Pooja Toshniwal PahariaDec 20 2022Reviewed by Benedette Cuffari, M.Sc. In a recent News & Views article published in the journal Nature Cardiovascular Research, researchers report the frequencies of novel postural orthostatic tachycardia syndrome -related diagnoses including POTS, fatigue, dysautonomia, Ehlers–Danlos syndrome, and mast cell diseases, prior to and after severe acute respiratory syndrome coronavirus 2 infection and coronavirus disease 2019 vaccination.
POTS is a common autonomic nervous system disorder that is characterized by tachycardia or an increase of 30 beats/minute or more during 10 minutes of being in the standing position and orthostatic intolerance symptoms. POTS symptomatology includes palpitations, pre-syncope, generalized weakness, light-headedness, nausea, and headache that lasts for more than three months.
About the study Electronic health records data from 284,592 COVID-19 vaccinees and 12,460 SARS-CoV-2-positive individuals were analyzed. The sample population of the study comprised 300,000 COVID-19 vaccinees from Los Angeles County in the United States of America. The assimilation of all new-onset POTS-related diagnoses together yielded marginally lower odds. Among SARS-CoV-2-positive individuals, the pre-COVID-19 incidence of new-onset POTS was 2% as compared to 3% post-COVID-19. Thus, the risk of developing POTS was greater among individuals with SARS-CoV-2 infections as compared to those after COVID-19 vaccination.
Nevertheless, the rate of new POTS diagnoses was more than five-fold greater post-COVID-19 as compared to that following vaccinations. This finding underpins the importance of vaccinations and can be referenced by healthcare professionals to reduce COVID-19 vaccine reluctance among the public.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2 biorxivpreprint PittHealthSci antibody antibodies vaccine vaccination SARSCoV2 COVID19 covid coronavirus
Read more »
Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infectionMilk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection medrxivpreprint UCSF SARSCoV2 COVID19 Booster Vaccine Vaccination
Read more »
What is the impact of cholesterol on SARS-CoV-2 Spike protein-mediated membrane fusion?Researchers assessed the impact of ceramide (CER) and cholesterol (CHOL) on membrane fusion mediated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Read more »
The potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in EnglandThe potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in England CDCgov ucl SARSCoV2 vaccine vaccination transmission covid coronavirus covid
Read more »
SARS-CoV-2 structural proteins trigger periodontal fibrosisResearchers examined the pathological impacts of the structural components of SARS-CoV-2 on human periodontal cells and tissue to understand the association between coronavirus disease 2019 (COVID-19) and deteriorating oral health.
Read more »
Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 bindingStudy finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding PLOSONE flavor fragrance compounds chemicals COVID19 coronavirus covid ACE2
Read more »